Guinea Discharges Last Ebola Patient – But New Findings About Long Virus Life Demand Vigilance 25/03/2021 Pokuaa Oduro-Bonsrah (Geneva Solutions) – As Guinea and the Democratic Republic of Congo discharge their last Ebola patients, following the most recent outbreak, new research points to the virus’ long lasting ability to lurk within the body. So while the 42 day countdown begins to the day when both countries can declare that the current outbreak is […] Continue reading -> European Parliament Signals Approval of Digital Green Certificate Scheme 25/03/2021 Raisa Santos European Parliament members (MEPs) expressed overwhelming support for a coronavirus-related “Digital Green Certificate” to ease travel within the European Union, voting by a more than two-thirds majority to accelerate approval by the summer. But parliamentarians also warned that all efforts to recover from COVID-19 will be void unless Europeans are vaccinated more quickly. “We need […] Continue reading -> India Investigates New SARS-CoV2 ‘Double Variant’ – Bearing Two Significant Spike Protein Mutations 25/03/2021 Menaka Rao NEW DELHI – Scientists have sequenced a new “double variant” of the coronavirus first identified in India – along with a handful of other variants of concern that are appearing during the second biggest wave of the virus since the pandemic began. The new double variant, bearing two significant mutations in the coronavirus spike protein, […] Continue reading -> Decolonizing Tuberculosis Care: A Perspective From The Global South On World TB Day 24/03/2021 Uzma Khan Tuberculosis care is quintessentially colonial, even in 2021. While many countries have been emancipated from their colonizers, the heritage of the colonial mindset, culture and even entire economies is deeply embedded within high burden TB countries in the post-colonial era. A disease of poverty, TB has historically been terribly neglected. Although the number one infectious […] Continue reading -> Norway Gives Up COVAX Doses Despite Domestic Pressure – ACT Accelerator proposes manufacturing task force 23/03/2021 Kerry Cullinan In a decisive act of global solidarity, Norway has offered almost a third of its allocation of COVAX vaccines to poorer countries, according to Dag-Inge Ulstein, Norway’s Minister of International Development. Norway has only fully vaccinated about 5% of its population – 260,000 people – and unlike many other European countries, it has not stockpiled […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Mayors Appeal for Equitable Access to Vaccines – Independent Panel calls for contributions ahead of WHO submission 19/03/2021 Kerry Cullinan Mayors from three capital cities in the global south have appealed for speedy “technology transfer” to enable them to produce their own COVID-19 vaccines at Friday’s World Health Organization (WHO) bi-weekly COVID-19 media briefing. The mayors’ appeal comes on the eve of a meeting next week between WHO Director General Dr Tedros Adhanom Ghebreyesus and […] Continue reading -> World Oral Health Day: Delivering Optimal Oral Health for All 19/03/2021 Gerhard Konrad Seeberger One of the unquantified side effects (or health impacts) of the pandemic has been in a place few people cared to look very deeply – that is our mouths. For significant parts of the past year, dentists’ chairs in many offices around the world sat empty – as COVID-19 disrupted routine dental treatments. During the early […] Continue reading -> Posts navigation Older postsNewer posts
European Parliament Signals Approval of Digital Green Certificate Scheme 25/03/2021 Raisa Santos European Parliament members (MEPs) expressed overwhelming support for a coronavirus-related “Digital Green Certificate” to ease travel within the European Union, voting by a more than two-thirds majority to accelerate approval by the summer. But parliamentarians also warned that all efforts to recover from COVID-19 will be void unless Europeans are vaccinated more quickly. “We need […] Continue reading -> India Investigates New SARS-CoV2 ‘Double Variant’ – Bearing Two Significant Spike Protein Mutations 25/03/2021 Menaka Rao NEW DELHI – Scientists have sequenced a new “double variant” of the coronavirus first identified in India – along with a handful of other variants of concern that are appearing during the second biggest wave of the virus since the pandemic began. The new double variant, bearing two significant mutations in the coronavirus spike protein, […] Continue reading -> Decolonizing Tuberculosis Care: A Perspective From The Global South On World TB Day 24/03/2021 Uzma Khan Tuberculosis care is quintessentially colonial, even in 2021. While many countries have been emancipated from their colonizers, the heritage of the colonial mindset, culture and even entire economies is deeply embedded within high burden TB countries in the post-colonial era. A disease of poverty, TB has historically been terribly neglected. Although the number one infectious […] Continue reading -> Norway Gives Up COVAX Doses Despite Domestic Pressure – ACT Accelerator proposes manufacturing task force 23/03/2021 Kerry Cullinan In a decisive act of global solidarity, Norway has offered almost a third of its allocation of COVAX vaccines to poorer countries, according to Dag-Inge Ulstein, Norway’s Minister of International Development. Norway has only fully vaccinated about 5% of its population – 260,000 people – and unlike many other European countries, it has not stockpiled […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Mayors Appeal for Equitable Access to Vaccines – Independent Panel calls for contributions ahead of WHO submission 19/03/2021 Kerry Cullinan Mayors from three capital cities in the global south have appealed for speedy “technology transfer” to enable them to produce their own COVID-19 vaccines at Friday’s World Health Organization (WHO) bi-weekly COVID-19 media briefing. The mayors’ appeal comes on the eve of a meeting next week between WHO Director General Dr Tedros Adhanom Ghebreyesus and […] Continue reading -> World Oral Health Day: Delivering Optimal Oral Health for All 19/03/2021 Gerhard Konrad Seeberger One of the unquantified side effects (or health impacts) of the pandemic has been in a place few people cared to look very deeply – that is our mouths. For significant parts of the past year, dentists’ chairs in many offices around the world sat empty – as COVID-19 disrupted routine dental treatments. During the early […] Continue reading -> Posts navigation Older postsNewer posts
India Investigates New SARS-CoV2 ‘Double Variant’ – Bearing Two Significant Spike Protein Mutations 25/03/2021 Menaka Rao NEW DELHI – Scientists have sequenced a new “double variant” of the coronavirus first identified in India – along with a handful of other variants of concern that are appearing during the second biggest wave of the virus since the pandemic began. The new double variant, bearing two significant mutations in the coronavirus spike protein, […] Continue reading -> Decolonizing Tuberculosis Care: A Perspective From The Global South On World TB Day 24/03/2021 Uzma Khan Tuberculosis care is quintessentially colonial, even in 2021. While many countries have been emancipated from their colonizers, the heritage of the colonial mindset, culture and even entire economies is deeply embedded within high burden TB countries in the post-colonial era. A disease of poverty, TB has historically been terribly neglected. Although the number one infectious […] Continue reading -> Norway Gives Up COVAX Doses Despite Domestic Pressure – ACT Accelerator proposes manufacturing task force 23/03/2021 Kerry Cullinan In a decisive act of global solidarity, Norway has offered almost a third of its allocation of COVAX vaccines to poorer countries, according to Dag-Inge Ulstein, Norway’s Minister of International Development. Norway has only fully vaccinated about 5% of its population – 260,000 people – and unlike many other European countries, it has not stockpiled […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Mayors Appeal for Equitable Access to Vaccines – Independent Panel calls for contributions ahead of WHO submission 19/03/2021 Kerry Cullinan Mayors from three capital cities in the global south have appealed for speedy “technology transfer” to enable them to produce their own COVID-19 vaccines at Friday’s World Health Organization (WHO) bi-weekly COVID-19 media briefing. The mayors’ appeal comes on the eve of a meeting next week between WHO Director General Dr Tedros Adhanom Ghebreyesus and […] Continue reading -> World Oral Health Day: Delivering Optimal Oral Health for All 19/03/2021 Gerhard Konrad Seeberger One of the unquantified side effects (or health impacts) of the pandemic has been in a place few people cared to look very deeply – that is our mouths. For significant parts of the past year, dentists’ chairs in many offices around the world sat empty – as COVID-19 disrupted routine dental treatments. During the early […] Continue reading -> Posts navigation Older postsNewer posts
Decolonizing Tuberculosis Care: A Perspective From The Global South On World TB Day 24/03/2021 Uzma Khan Tuberculosis care is quintessentially colonial, even in 2021. While many countries have been emancipated from their colonizers, the heritage of the colonial mindset, culture and even entire economies is deeply embedded within high burden TB countries in the post-colonial era. A disease of poverty, TB has historically been terribly neglected. Although the number one infectious […] Continue reading -> Norway Gives Up COVAX Doses Despite Domestic Pressure – ACT Accelerator proposes manufacturing task force 23/03/2021 Kerry Cullinan In a decisive act of global solidarity, Norway has offered almost a third of its allocation of COVAX vaccines to poorer countries, according to Dag-Inge Ulstein, Norway’s Minister of International Development. Norway has only fully vaccinated about 5% of its population – 260,000 people – and unlike many other European countries, it has not stockpiled […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Mayors Appeal for Equitable Access to Vaccines – Independent Panel calls for contributions ahead of WHO submission 19/03/2021 Kerry Cullinan Mayors from three capital cities in the global south have appealed for speedy “technology transfer” to enable them to produce their own COVID-19 vaccines at Friday’s World Health Organization (WHO) bi-weekly COVID-19 media briefing. The mayors’ appeal comes on the eve of a meeting next week between WHO Director General Dr Tedros Adhanom Ghebreyesus and […] Continue reading -> World Oral Health Day: Delivering Optimal Oral Health for All 19/03/2021 Gerhard Konrad Seeberger One of the unquantified side effects (or health impacts) of the pandemic has been in a place few people cared to look very deeply – that is our mouths. For significant parts of the past year, dentists’ chairs in many offices around the world sat empty – as COVID-19 disrupted routine dental treatments. During the early […] Continue reading -> Posts navigation Older postsNewer posts
Norway Gives Up COVAX Doses Despite Domestic Pressure – ACT Accelerator proposes manufacturing task force 23/03/2021 Kerry Cullinan In a decisive act of global solidarity, Norway has offered almost a third of its allocation of COVAX vaccines to poorer countries, according to Dag-Inge Ulstein, Norway’s Minister of International Development. Norway has only fully vaccinated about 5% of its population – 260,000 people – and unlike many other European countries, it has not stockpiled […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Mayors Appeal for Equitable Access to Vaccines – Independent Panel calls for contributions ahead of WHO submission 19/03/2021 Kerry Cullinan Mayors from three capital cities in the global south have appealed for speedy “technology transfer” to enable them to produce their own COVID-19 vaccines at Friday’s World Health Organization (WHO) bi-weekly COVID-19 media briefing. The mayors’ appeal comes on the eve of a meeting next week between WHO Director General Dr Tedros Adhanom Ghebreyesus and […] Continue reading -> World Oral Health Day: Delivering Optimal Oral Health for All 19/03/2021 Gerhard Konrad Seeberger One of the unquantified side effects (or health impacts) of the pandemic has been in a place few people cared to look very deeply – that is our mouths. For significant parts of the past year, dentists’ chairs in many offices around the world sat empty – as COVID-19 disrupted routine dental treatments. During the early […] Continue reading -> Posts navigation Older postsNewer posts
US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Mayors Appeal for Equitable Access to Vaccines – Independent Panel calls for contributions ahead of WHO submission 19/03/2021 Kerry Cullinan Mayors from three capital cities in the global south have appealed for speedy “technology transfer” to enable them to produce their own COVID-19 vaccines at Friday’s World Health Organization (WHO) bi-weekly COVID-19 media briefing. The mayors’ appeal comes on the eve of a meeting next week between WHO Director General Dr Tedros Adhanom Ghebreyesus and […] Continue reading -> World Oral Health Day: Delivering Optimal Oral Health for All 19/03/2021 Gerhard Konrad Seeberger One of the unquantified side effects (or health impacts) of the pandemic has been in a place few people cared to look very deeply – that is our mouths. For significant parts of the past year, dentists’ chairs in many offices around the world sat empty – as COVID-19 disrupted routine dental treatments. During the early […] Continue reading -> Posts navigation Older postsNewer posts
AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Mayors Appeal for Equitable Access to Vaccines – Independent Panel calls for contributions ahead of WHO submission 19/03/2021 Kerry Cullinan Mayors from three capital cities in the global south have appealed for speedy “technology transfer” to enable them to produce their own COVID-19 vaccines at Friday’s World Health Organization (WHO) bi-weekly COVID-19 media briefing. The mayors’ appeal comes on the eve of a meeting next week between WHO Director General Dr Tedros Adhanom Ghebreyesus and […] Continue reading -> World Oral Health Day: Delivering Optimal Oral Health for All 19/03/2021 Gerhard Konrad Seeberger One of the unquantified side effects (or health impacts) of the pandemic has been in a place few people cared to look very deeply – that is our mouths. For significant parts of the past year, dentists’ chairs in many offices around the world sat empty – as COVID-19 disrupted routine dental treatments. During the early […] Continue reading -> Posts navigation Older postsNewer posts
Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Mayors Appeal for Equitable Access to Vaccines – Independent Panel calls for contributions ahead of WHO submission 19/03/2021 Kerry Cullinan Mayors from three capital cities in the global south have appealed for speedy “technology transfer” to enable them to produce their own COVID-19 vaccines at Friday’s World Health Organization (WHO) bi-weekly COVID-19 media briefing. The mayors’ appeal comes on the eve of a meeting next week between WHO Director General Dr Tedros Adhanom Ghebreyesus and […] Continue reading -> World Oral Health Day: Delivering Optimal Oral Health for All 19/03/2021 Gerhard Konrad Seeberger One of the unquantified side effects (or health impacts) of the pandemic has been in a place few people cared to look very deeply – that is our mouths. For significant parts of the past year, dentists’ chairs in many offices around the world sat empty – as COVID-19 disrupted routine dental treatments. During the early […] Continue reading -> Posts navigation Older postsNewer posts
Mayors Appeal for Equitable Access to Vaccines – Independent Panel calls for contributions ahead of WHO submission 19/03/2021 Kerry Cullinan Mayors from three capital cities in the global south have appealed for speedy “technology transfer” to enable them to produce their own COVID-19 vaccines at Friday’s World Health Organization (WHO) bi-weekly COVID-19 media briefing. The mayors’ appeal comes on the eve of a meeting next week between WHO Director General Dr Tedros Adhanom Ghebreyesus and […] Continue reading -> World Oral Health Day: Delivering Optimal Oral Health for All 19/03/2021 Gerhard Konrad Seeberger One of the unquantified side effects (or health impacts) of the pandemic has been in a place few people cared to look very deeply – that is our mouths. For significant parts of the past year, dentists’ chairs in many offices around the world sat empty – as COVID-19 disrupted routine dental treatments. During the early […] Continue reading -> Posts navigation Older postsNewer posts
World Oral Health Day: Delivering Optimal Oral Health for All 19/03/2021 Gerhard Konrad Seeberger One of the unquantified side effects (or health impacts) of the pandemic has been in a place few people cared to look very deeply – that is our mouths. For significant parts of the past year, dentists’ chairs in many offices around the world sat empty – as COVID-19 disrupted routine dental treatments. During the early […] Continue reading -> Posts navigation Older postsNewer posts